Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Biotech Nonprofit Bucks the Boston Trend with Buy of Building in Woodbridge
Cure Rare Disease, a nonprofit biotechnology company, has acquired 4 Research Drive in Woodbridge, CT, where the organization will relocate from its current headquarters in Boston.
The 30,000-square-foot facility was purchased by CRD to continue its mission of developing therapeutics for rare and ultra-rare neuromuscular diseases through a novel framework. CRD will also make 15,000 square feet of space available for lease to other life science and healthcare firms.
“We are excited to join the Woodbridge and greater New Haven communities to deepen our R&D efforts for rare disease patients while also offering biotechnology companies the opportunity to access Class A life sciences space in the New Haven area,” said CRD founder and CEO, Rich Horgan.
The space will be extensively renovated through the end of 2022 and into 2023, to improve the exterior, interior and parking lot of the facility.
Dow Realty Co., is handling leasing.
- ◦Sale/Acquisition
